JULIA LEE: Open Payments
NPI 1093280604 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,907 in 122 payments from 15 companies in 2025. Trend: 2023 $1,615 · 2024 $2,158 · 2025 $2,907
Food & beverage: $2,887Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $983 |
| Ardelyx, Inc. | 15 | $472 |
| PFIZER INC. | 8 | $282 |
| GENZYME CORPORATION | 5 | $237 |
| QOL Medical, LLC | 9 | $164 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $133 |
| Madrigal Pharmaceuticals | 5 | $124 |
| Celltrion USA Inc. | 5 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
| Phathom Pharmaceuticals, Inc. | 6 | $98 |
Products named: IBSRELA, RINVOQ, LINZESS, CREON, DUPIXENT, Sucraid, XELJANZ, REZDIFFRA.
Industry payments across CA — which companies pay providers there.
